Company intelligence / Profile preview

WHEB Ventures

London, United Kingdom

Ownership: Private
Employees: ~15
Development stage: Other

Overview

WHEB Ventures is a specialist investment firm based in London that focuses on the sustainability and healthcare sectors. The firm provides growth capital to European companies that offer innovative solutions to global challenges, such as resource scarcity and aging populations. In the life sciences arena, WHEB Ventures has a track record of investing in diverse areas including regenerative medicine, molecular diagnostics, and specialty pharmaceuticals. Notable investments include companies like TiGenix, Oxford Immunotec, and Apeiron Biologics. As a pioneer in impact investing, the firm integrates environmental, social, and governance (ESG) criteria into its investment process. WHEB Ventures operates as part of the broader WHEB Group, which also manages sustainability-themed listed equity funds.

Industry: Investors

Beyond the preview

Go deeper on WHEB Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on WHEB Ventures.

Explore the full profile